Watson Pharmaceuticals Invests in $15M New Jersey Expansion
05/27/2010
"Over the past year, we have outgrown our current administrative headquarters site, as our U.S. and global business has rapidly grown," said Paul Biscaro, Watson president and CEO. "This new facility will ensure that we have a single location for the leadership and shared services functions that are driving our global growth."
New Jersey's Business Employment Incentive Program (BEIP) has extended Watson a grant of approximately $7.3 million over the next 10 years from the state's Economic Development Authority. It has also been approved for a $290,000 Business Retention and Relocation Assistance Grant (BRRAG) to retain 200 jobs in New Jersey.
Watson was the country's third largest producer of generic drugs in 2009 based on prescriptions dispensed. It specializes in drugs for urology and women's health.
Project Announcements
Davis Timber Company Expands DeRidder, Louisiana, Manufacturing Operations
04/28/2026
Blevins Asphalt Expands Mount Vernon, Missouri, Maintenance Operations
04/28/2026
Niagara Bottling Plans Perth, New York, Production-Warehouse Operations
04/26/2026
Marubeni-Itochu Steel America Plans Osceola, Arkansas, Flat-Rolled Steel Operations
04/25/2026
Corderill Plans Meridian, Mississippi, Operations
04/25/2026
Ferrara Candy Plans Orangeburg County, South Carolina, Production Operations
04/25/2026
Most Read
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
40th Annual Corporate and 22nd Annual Consultant Site Selection Survey Results
Q1 2026
-
Where Workforce Capacity Is Being Built — and Where It’s Being Deployed
Q1 2026
-
Last Word: Don’t Lose by Winning
Q1 2026